Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Patents
Corbyn’s Compulsory Licenses. Will they work?
Ellen 't Hoen
-
September 26, 2019
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in...
Ellen 't Hoen
-
February 22, 2019
New Database Documents the Power of TRIPS Flexibilities
Ellen 't Hoen
-
November 27, 2018
Dutch health insurance company Menzis takes AstraZeneca to court over patent...
Ellen 't Hoen
-
September 20, 2018
How patents, data exclusivity and SPCs interact to extend market exclusivity...
Pascale Boulet
-
July 10, 2018
Brazil’s Federal Court Reviews Medicines Mailbox Patents
Ellen 't Hoen
-
April 29, 2018
Dolutegravir Patent Licences Can Provide Access To All
Ellen 't Hoen
-
July 26, 2017
Gilead’s sofosbuvir patent in India – options for global access to...
Ellen 't Hoen
-
May 26, 2016
1
2
Page 2 of 2
This work is licensed under Creative Commons.